Cargando…
Serological testing of blood donors to characterise the impact of COVID-19 in Melbourne, Australia, 2020
Rapidly identifying and isolating people with acute SARS-CoV-2 infection has been a core strategy to contain COVID-19 in Australia, but a proportion of infections go undetected. We estimated SARS-CoV-2 specific antibody prevalence (seroprevalence) among blood donors in metropolitan Melbourne followi...
Autores principales: | Machalek, Dorothy A., Vette, Kaitlyn M., Downes, Marnie, Carlin, John B., Nicholson, Suellen, Hirani, Rena, Irving, David O., Gosbell, Iain B., Gidding, Heather F., Shilling, Hannah, Aung, Eithandee, Macartney, Kristine, Kaldor, John M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9258843/ https://www.ncbi.nlm.nih.gov/pubmed/35793307 http://dx.doi.org/10.1371/journal.pone.0265858 |
Ejemplares similares
-
Seroprevalence of Severe Acute Respiratory Syndrome Coronavirus 2-Specific Antibodies in Australia After the First Epidemic Wave in 2020: A National Survey
por: Vette, Kaitlyn M, et al.
Publicado: (2022) -
The seroprevalence of SARS‐CoV‐2‐specific antibodies in children, Australia, November 2020 – March 2021
por: Koirala, Archana, et al.
Publicado: (2022) -
Evaluation of serological assays for SARS-CoV-2 antibody testing from dried blood spots collected from cohorts with prior SARS-CoV-2 infection
por: Catlett, Beth, et al.
Publicado: (2022) -
An update on Covid-19 serology
por: Kinsella, Paul M., et al.
Publicado: (2022) -
Melbourne Notes
Publicado: (1909)